Add to ORKGHigh within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantatio
High intrapatient variability (IPV) of tacrolimus concentrations is increasingly recognized as a pre...
A high intrapatient variability (IPV) in tacrolimus exposure is a risk factor for poor long-term out...
Efficacy and safety of tacrolimus compared with ciclosporin A in renal transplantation: three-year o...
We hypothesized that a high within-patient variability in clearance of tacrolimus and mycophenolate ...
Background. We hypothesized that a high within-patient variability in clearance of tacrolimus and my...
Tacrolimus is a critical dose drug with a considerable intrapatient variability (IPV) in its pharmac...
Item does not contain fulltextTacrolimus is a critical dose drug with a considerable intrapatient va...
Tacrolimus (TAC) is used for immunosuppression after kidney transplantation. Non-optimal TAC therapy...
Abstract High intra-patient variability (IPV) of tacrolimus trough concentrations is increasingly re...
Background: High intrapatient tacrolimus variability has been associated with worse clinical outcome...
This study aimed to determine the impact of tacrolimus (TAC) trough level (C0) intrapatient variabil...
Background: High intrapatient tacrolimus variability has been associated with worse clinical outcome...
Background: Kidney transplant recipients with high intrapatient variability (IPV) in tacrolimus (Tac...
Tacrolimus has significantly improved outcomes for kidney transplant patients and remains the corner...
Background: High intrapatient variability (IPV) in tacrolimus exposure has been associated with an i...
High intrapatient variability (IPV) of tacrolimus concentrations is increasingly recognized as a pre...
A high intrapatient variability (IPV) in tacrolimus exposure is a risk factor for poor long-term out...
Efficacy and safety of tacrolimus compared with ciclosporin A in renal transplantation: three-year o...
We hypothesized that a high within-patient variability in clearance of tacrolimus and mycophenolate ...
Background. We hypothesized that a high within-patient variability in clearance of tacrolimus and my...
Tacrolimus is a critical dose drug with a considerable intrapatient variability (IPV) in its pharmac...
Item does not contain fulltextTacrolimus is a critical dose drug with a considerable intrapatient va...
Tacrolimus (TAC) is used for immunosuppression after kidney transplantation. Non-optimal TAC therapy...
Abstract High intra-patient variability (IPV) of tacrolimus trough concentrations is increasingly re...
Background: High intrapatient tacrolimus variability has been associated with worse clinical outcome...
This study aimed to determine the impact of tacrolimus (TAC) trough level (C0) intrapatient variabil...
Background: High intrapatient tacrolimus variability has been associated with worse clinical outcome...
Background: Kidney transplant recipients with high intrapatient variability (IPV) in tacrolimus (Tac...
Tacrolimus has significantly improved outcomes for kidney transplant patients and remains the corner...
Background: High intrapatient variability (IPV) in tacrolimus exposure has been associated with an i...
High intrapatient variability (IPV) of tacrolimus concentrations is increasingly recognized as a pre...
A high intrapatient variability (IPV) in tacrolimus exposure is a risk factor for poor long-term out...
Efficacy and safety of tacrolimus compared with ciclosporin A in renal transplantation: three-year o...